Tumor News and Research

RSS

Large-scale screen efficiently identifies drugs that are potent cancer-killers

UC San Francisco scientists have designed a large-scale screen that efficiently identifies drugs that are potent cancer-killers when combined, but only weakly effective when used alone.

10 Apr 2019

Proton therapy shows excellent outcomes, minimal side effects in high-risk neuroblastoma patients

Researchers from Children's Hospital of Philadelphia and the Perelman School of Medicine at the University of Pennsylvania analyzed the largest cohort to date of pediatric patients with high-risk neuroblastoma treated with proton radiation therapy, finding both that proton therapy was effective at reducing tumors and demonstrated minimal toxicity to surrounding organs.

10 Apr 2019

Single-cell sequencing sheds light on landscape of myeloid cells in lung tumors

The recent emergence of immunotherapy has marked a sea change in research and care for many forms of cancer, bringing new hope to patients and families around the world. For those who respond to treatment, the results can be dramatic.

10 Apr 2019

New technology provides clearer picture to clinicians treating gynecological cancer

New technology developed at Western University is providing an improved way for radiation oncologists to deliver treatment to women with gynecological cancers, including vaginal, cervical and uterine cancer.

9 Apr 2019

Jewish General Hospital initiates new clinical trial to avoid surgery in breast cancer patients

In a radical departure from established treatment protocols, Dr. Mark Basik, a surgical oncologist at Segal Cancer Centre at the Jewish General Hospital and senior investigator at the Lady Davis Institute, is leading an international effort that will lead to a clinical trial to forego surgery in breast cancer patients who show no signs of residual cancer following a course of pre-operative chemotherapy.

9 Apr 2019

TGen review associates a gene with hepatocellular carcinoma

Hepatocellular carcinoma is a long medical name for the most common form of liver cancer, a malignancy whose incidence has nearly doubled over the past decade, making it the fastest growing type of cancer in the U.S., and the third-leading cause of cancer-related death worldwide.

9 Apr 2019

Biologists analyze available methods of targeted drug delivery to malignant tumors

A team of biologists from Sechenov First Moscow State Medical University and Lobachevsky University analyzed available methods of targeted drug delivery to malignant tumors.

9 Apr 2019

Cancer vaccine injected into tumour could kill all cancer cells

Researchers have developed an experimental cancer vaccine that when injected into a single tumour can help trigger the immune system to kill the cancer cells circulating within the body. The results of the study titled, “Systemic clinical tumor regressions and potentiation of PD1 blockade with in situ vaccination,” were published in the latest issue of the journal Nature Medicine, this week, Monday.

9 Apr 2019

New findings create opportunity to test new treatments for sarcoma

The origin of certain cancers in the sarcoma group is associated with a hitherto unknown interaction among different proteins. Findings now being presented create the opportunity to test new treatments of these forms of sarcoma.

9 Apr 2019

Scientists visualize immune cells fighting blood cancer for the first time

When cancer escapes the immune system, our defenses are rendered powerless and are unable to fight against the disease.

8 Apr 2019

New clinical trials to investigate combination immunotherapy for treating advanced cancers

City of Hope physician-scientists recently opened two clinical trials to investigate a combination of cytokines and immunotherapy that may be able to transform nearly-impossible-to-treat cancer into a disease that can be corralled into remission.

8 Apr 2019

Immune cells key to predicting outcomes in cancer patients, study suggests

Scientists have identified key changes in immune cells within cancerous tumors that could help improve the development of treatments.

8 Apr 2019

Celltrion and iProgen Biotech announce partnership for development of novel ADCs

On April 8, Celltrion and the Canada-based iProgen Biotech Inc. announced to agree to partner for the development of novel ADCs against validated antibody targets, including HER2 and CD20.

8 Apr 2019

High-dose standard radiation treatment well-tolerated by patients with centrally located NSCLC

Stereotactic Body Radiotherapy, a high-dose, precisely delivered radiotherapy, is considered the standard treatment for patients with medically inoperable, node-negative, non-small cell lung cancer.

5 Apr 2019

Researchers create online tool to determine genetic diversity and ancestry of cell lines

Cancer is a highly varied disease, with genetic differences among different tumor types, individuals and ancestral populations. These genetic differences can impact disease aggressiveness, the type of disease, and the response to therapy.

5 Apr 2019

Inauguration of NIDD, the Neuroimmunology Drug Development Summit

NIDD is the industry’s first meeting dedicated to targeting neuroimmunological mechanisms in order to develop clinically efficacious therapeutics.

From Neuroimmunology Drug Development 5 Apr 2019

Magnetic nanoparticles can 'heat up' tumor cells

Unfortunately, cancer isn't simply a single disease, and some types, like pancreas, brain or liver tumors, are still difficult to treat with chemotherapy, radiation therapy or surgery, leading to low survival rates for patients.

5 Apr 2019

Study offers novel insights into how a major tumor suppressor pathway becomes deactivated

The Hippo pathway is an important biological tumor suppressor program that controls cell growth and organ size in humans.

5 Apr 2019

Newly developed melanin nanoparticles could slow tumor growth

The dark skin pigment melanin protects us from the sun's damaging rays by absorbing light energy and converting it to heat.

5 Apr 2019

Embryo selection for IVF can be optimized using artificial intelligence technique

A new artificial intelligence approach by Weill Cornell Medicine investigators can identify with a great degree of accuracy whether a 5-day-old, in vitro fertilized human embryo has a high potential to progress to a successful pregnancy.

5 Apr 2019

Tumor News and Research

Large-scale screen efficiently identifies drugs that are potent cancer-killers

Proton therapy shows excellent outcomes, minimal side effects in high-risk neuroblastoma patients

Single-cell sequencing sheds light on landscape of myeloid cells in lung tumors

New technology provides clearer picture to clinicians treating gynecological cancer

Jewish General Hospital initiates new clinical trial to avoid surgery in breast cancer patients

TGen review associates a gene with hepatocellular carcinoma

Biologists analyze available methods of targeted drug delivery to malignant tumors

Cancer vaccine injected into tumour could kill all cancer cells

New findings create opportunity to test new treatments for sarcoma

Scientists visualize immune cells fighting blood cancer for the first time

New clinical trials to investigate combination immunotherapy for treating advanced cancers

Immune cells key to predicting outcomes in cancer patients, study suggests

Celltrion and iProgen Biotech announce partnership for development of novel ADCs

High-dose standard radiation treatment well-tolerated by patients with centrally located NSCLC

Researchers create online tool to determine genetic diversity and ancestry of cell lines

Inauguration of NIDD, the Neuroimmunology Drug Development Summit

Magnetic nanoparticles can 'heat up' tumor cells

Study offers novel insights into how a major tumor suppressor pathway becomes deactivated

Newly developed melanin nanoparticles could slow tumor growth

Embryo selection for IVF can be optimized using artificial intelligence technique

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News